VisionVet, San Giovanni in Persiceto, Bologna, Italy.
Department of Medical Informatics and Biostatistics, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
PLoS One. 2020 Nov 5;15(11):e0241567. doi: 10.1371/journal.pone.0241567. eCollection 2020.
The aim of the present study was to determine and compare the degree and duration of corneal anesthesia following topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride treatment in healthy rats. A randomized, blinded, crossover study was conducted on 20 healthy adult Wistar rats, following complete physical and ophthalmological examination. Baseline corneal touch threshold (CTT) was determined in the central corneal area of both eyes with a Cochet-Bonnet aesthesiometer, in mm filament length. Oxybuprocaine was randomly applied to one eye and 0.9% sterile sodium chloride solution was instilled into the contralateral eye. Subsequent CTT measurements were performed in both eyes 5 minutes after topical application and at 5-minute intervals thereafter for 75-minutes in the anesthetized eye. Following a 2-week washout period, this protocol was repeated with ropivacaine. Quantitative data were summarized as mean ± standard deviation, median and inter-quartile range (Q1-Q3). Repeated measures data were analyzed over time and between treatments using Friedman test and Wilcoxon signed-rank test with Bonferroni adjustment (p < 0.05). Baseline CTT values were 60 mm in all eyes. With oxybuprocaine, CTT values decreased significantly for 65 minutes (0-55 mm; p = 0.002) when compared with baseline; the maximal anesthetic effect (no blink response at 5 mm filament length) was maintained for up to 15 minutes (p < 0.0001). With ropivacaine, CTT values were significantly lower than baseline for 30 minutes (0-55 mm; p = 0.002), with a maximal anesthetic effect recorded at 5 minutes in 18 eyes (p < 0.0001). Oxybuprocaine induced a significantly lower CTT than ropivacaine (p = 0.002) from 10 to 65 minutes following topical application. Both anesthetic agents induced significant corneal anesthesia; however, oxybuprocaine provided a greater and longer anesthetic effect, making it more suitable for potentially painful ophthalmologic procedures.
本研究旨在确定并比较 0.4%盐酸奥布卡因眼用溶液和 1%盐酸罗哌卡因治疗后健康大鼠角膜麻醉的程度和持续时间。对 20 只健康成年 Wistar 大鼠进行随机、双盲、交叉研究,在进行完整的体格检查和眼科检查后。使用 Cochet-Bonnet 触觉计测量双眼中央角膜区域的角膜触觉阈值(CTT),以毫米长的细丝长度表示。奥布卡因随机应用于一只眼,对侧眼滴注 0.9%无菌生理盐水。在局部应用后 5 分钟和此后的 75 分钟内,每 5 分钟测量一次麻醉眼的 CTT。在 2 周洗脱期后,用罗哌卡因重复该方案。定量数据以平均值 ±标准差、中位数和四分位间距(Q1-Q3)表示。使用 Friedman 检验和 Wilcoxon 符号秩检验(Bonferroni 校正)分析重复测量数据随时间和处理的变化(p < 0.05)。所有眼睛的基线 CTT 值均为 60mm。奥布卡因治疗后 65 分钟(0-55mm;p=0.002),CTT 值较基线显著下降;最大麻醉效果(5mm 细丝长度无眨眼反应)持续至 15 分钟(p<0.0001)。罗哌卡因治疗后 30 分钟(0-55mm;p=0.002),CTT 值较基线显著降低,18 只眼在 5 分钟时记录到最大麻醉效果(p<0.0001)。奥布卡因治疗后 10 至 65 分钟,CTT 值明显低于罗哌卡因(p=0.002)。两种麻醉剂均引起显著的角膜麻醉;然而,奥布卡因产生的麻醉效果更大且持续时间更长,使其更适合潜在疼痛的眼科手术。